Deerfield Private Design Fund III, L.P. sold $10.1M of ARS Pharmaceuticals (SPRY)

Executed Nov 11 2024, disclosed Nov 13 2024, 2 days later.

Value, as filed

$10.1M

563,270 sh across 8 lots

Executed

Nov 11 2024

the trade date, as filed

Disclosed

Nov 13 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DP Deerfield Private Design Fund III, L.P. 10% owner profile →

Deerfield Private Design Fund III, L.P. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in SPRY. The largest single filing was $10.1M of SPRY (563,270 sh across 8 lots, as filed), executed Nov 11 2024.

The name

SPRY SPRY SPRY · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→